人对SK&F 92657的评估，一种具有血管舒张和β-肾上腺素能受体阻断活性的新型化合物[会议论文集] - Suppr

Suppr

超能文献

Assessment in man of SK & F 92657, a novel compound with vasodilator and beta-adrenoceptor blocking activity [proceedings].

作者信息

Bell A, Boyce M J, Burland W L, Underwood D D

出版信息

Br J Clin Pharmacol. 1980 Mar;9(3):299P-300P.

PMID:6102473

Abstract

摘要

相似文献

Assessment in man of SK & F 92657, a novel compound with vasodilator and beta-adrenoceptor blocking activity [proceedings].人对SK&F 92657的评估，一种具有血管舒张和β-肾上腺素能受体阻断活性的新型化合物[会议论文集]

Br J Clin Pharmacol. 1980 Mar;9(3):299P-300P.

An assessment of beta-adrenoceptor blockade in man by SK & F 92657, a new drug with combined vasodilator and beta-adrenoceptor blocking actions, and comparison with propranolol [proceedings].用兼具血管舒张和β-肾上腺素能受体阻断作用的新药SK&F 92657对人体β-肾上腺素能受体阻断作用的评估，并与普萘洛尔作比较[会议论文集]

Br J Clin Pharmacol. 1980 Mar;9(3):300P-301P. doi: 10.1111/j.1365-2125.1980.tb04858.x.

Investigation of a combined arteriolar dilator and beta-adrenoceptor antagonist (SK & F 92657) in the peripheral vessels of man.一种联合小动脉扩张剂和β-肾上腺素能受体拮抗剂（SK & F 92657）在人体外周血管中的研究。

Br J Clin Pharmacol. 1980 Dec;10(6):567-71. doi: 10.1111/j.1365-2125.1980.tb00512.x.

Effects of SK & F 92657 on the superficial hand veins and forearm arterioles of man [proceedings].SK&F 92657对人体手部浅静脉和前臂小动脉的影响[会议论文集]

Br J Clin Pharmacol. 1980 Mar;9(3):301P. doi: 10.1111/j.1365-2125.1980.tb04859.x.

[Behavior of arterial pressure, hemodynamic parameters, sympathetic nervous system activity and plasma volume during treatment with a vasodilating and beta-blocking drug in essential hypertension patients].

Boll Soc Ital Cardiol. 1981;26(11):1871-4.

Dose-response relationship of prizidilol hydrochloride (SK&F 92657): a comparison between acute and chronic effects in patients with essential hypertension.盐酸普齐地洛（SK&F 92657）的剂量-反应关系：原发性高血压患者急性与慢性效应的比较

Int J Clin Pharmacol Res. 1984;4(2):155-63.

[Continuous intra-arterial pressure recording for 24 hours under basal conditions and during therapy with prizidilol, a vasodilating and beta-blocking drug].

Cardiologia. 1983 Feb;28(2):127-31.

Beta-blocking agents with vasodilator activity.

J Hypertens Suppl. 1993 Jun;11(4):S37-40.

beta(3)-Adrenoceptor stimulation on top of beta(1)-adrenoceptor blockade "Stop or Encore?".在β1肾上腺素能受体阻滞剂基础上加用β3肾上腺素能受体激动剂：“停止还是继续？”

J Am Coll Cardiol. 2009 Apr 28;53(17):1539-42. doi: 10.1016/j.jacc.2009.01.048.

[Nebivolol: a beta blocker with vasodilator properties].奈必洛尔：一种具有血管舒张特性的β受体阻滞剂

Praxis (Bern 1994). 2000 Apr 6;89(15):631-3.

引用本文的文献

Cardiovascular effects in man of intravenous prizidilol hydrochloride (SK&F 92657); a new antihypertensive agent.新型抗高血压药物盐酸普齐地洛（SK&F 92657）对人体心血管系统的影响

Br J Clin Pharmacol. 1981 Oct;12(4):567-72. doi: 10.1111/j.1365-2125.1981.tb01266.x.

Metal binding by pharmaceuticals. Part 4. A comparative investigation of the interaction of metal ions with hydralazine, prizidilol and related compounds.药物与金属的结合。第4部分。金属离子与肼屈嗪、普尼地洛及相关化合物相互作用的比较研究。

Agents Actions. 1984 Jan;14(1):113-20. doi: 10.1007/BF01966843.

Prizidilol, a combined vasodilatory and beta-adrenoceptor blocking drug, in primary hypertension. A long-term efficacy, tolerance and pharmacokinetic study.普齐地洛，一种兼具血管舒张和β-肾上腺素能受体阻滞作用的药物，用于原发性高血压。一项长期疗效、耐受性及药代动力学研究。

Eur J Clin Pharmacol. 1983;25(2):179-86. doi: 10.1007/BF00543788.

Prizidilol (SK & F 92657), a new vasodilator with beta-blocking properties in the treatment of essential hypertension.普齐地洛（SK&F 92657），一种具有β受体阻滞特性的新型血管扩张剂，用于治疗原发性高血压。

Eur J Clin Pharmacol. 1982;23(5):411-5. doi: 10.1007/BF00605990.

Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.新型抗高血压药盐酸普齐地洛（SK & F 92657）与普萘洛尔和肼屈嗪在正常志愿者体内的比较：盐酸普齐地洛具有β-肾上腺素受体拮抗和血管舒张活性

Br J Clin Pharmacol. 1981 Oct;12(4):573-8. doi: 10.1111/j.1365-2125.1981.tb01267.x.

Comparative beta-adrenoceptor blocking effect and pharmacokinetics of bucindolol and propranolol in man.布新洛尔与普萘洛尔对人体β-肾上腺素能受体的阻断作用及药代动力学比较

Eur J Clin Pharmacol. 1985;27(6):649-56. doi: 10.1007/BF00547043.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验